I read an update from fund manager DMX saying they were asking management to divest Sofihub because it was a drain on cash flow. I do agree Hazza that the two remaining businesses are pretty small and have limited growth prospects (niche area as you say) as there are only so many pharmacists out there who are accredited to do these medication reviews. The admin costs of being asx listed are going to mean limited profits flow to shareholders and im struggling to see how this scales to a larger company.
News: CTQ Careteq Announces Divestment Of Sofihub Business, page-3
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CTQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.845M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1062816 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.5¢ | 540004 | 1 |
View Market Depth
| Last trade - 16.12pm 10/10/2024 (20 minute delay) ? |
| CTQ (ASX) Chart |
Day chart unavailable